Question 17 • VA_Pharmacology_A
The Hatch-Waxman Amendment created an abbreviated approval pathway for generic drugs shown to be therapeutically equivalent to brand-name drugs. This lets generic manufacturers rely on existing evidence of the brand drug’s safety and effectiveness instead of repeating the full approval process, reducing time and cost. The Orange Book supports the system by listing patent information, but the streamlined approval process is the main way the law encourages generic competition.
AI-written and checked against the verified answer.